Neurofibromatosis 1 (NF1) is a neurocutaneous disorder with a heterogenous presentation affecting 1 in 2500 to 1 in 3000 births. Our understanding of the pathogenesis of NF1 has increased dramatically since the discovery of the NF1 gene in 1990 and the role its product, neurofibromin, plays in tumor suppression. This book provides new research on the diagnosis, management and health impacts of NF.
This book, edited by Matthias Karajannis, MD, MS and Jeffrey Allen, MD, who direct the Comprehensive NF Center at NYU Langone Medical Center in New York, represents a valuable resource for both scientists and clinicians involved in NF1 ...
This book discusses the diagnosis, managements and clinical outcomes for neurofibromatosis.
Thus began my quest to find help for my daughter—one that would take many unexpected and nearly tragic turns.Rising Above: Facing the Dragon of Neurofibromatosisis the true account of Beth's indomitable, uplifting spirit while coping with ...
This book is written for a broad readership ranging from students to professionals. It provides the reader with a basic overview of the disease before discussing the most recent research and therapeutic developments in detail.